Atlas Trials

Shortening Radiation Course Duration Using Simultaneous Integrated Boost With Lower Intensity Elective Nodal Dosing and Concurrent Chemotherapy for High-Risk Anal Squamous Cell Carcinoma

Clinical trial NCT07775209 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07775209
Sponsor
University of Vermont Medical Center
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Anal Cancer
Start date
2029-05-01
Primary completion
2039-05-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.